TLX007-CDx is a cold kit designed for the preparation of PSMA-targeted PET imaging for prostate cancer. It leverages ...

TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...

Researchers from the Wellcome Sanger Institute and partners have carried out a comprehensive analysis of cancer cells, identifying 370 ‘priority’ targets that could be used to develop new drug ...

(RTTNews) - Celldex Therapeutics, Inc (CLDX) Monday reported positive preclinical data for CDX-622, a bispecific antibody targeting inflammation and fibrosis through dual inhibition of thymic ...

In the November election, voters approved Proposition 36, which toughened anti-crime laws by turning many drug and theft crimes into felonies. It turned back the sentencing reforms from 2014’s ...

- CDX-622 inhibits SCF and TSLP-dependent inflammatory signatures in human skin - - Phase 1 study in healthy volunteers ongoing - HAMPTON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- Celldex ...